Skip to content

A study of the safety and effectiveness of remote ischemic conditioning combined with passive exercise in acute cerebral infarction

A study of the safety and effectiveness of remote ischemic conditioning combined with passive exercise in acute cerebral infarction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127739
Enrollment
Unknown
Registered
2026-07-06
Start date
2025-01-14
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute cerebral infarction

Interventions

RIC+Passive Exercise group:RIC is administered twice daily for 7 days, starting within 24 hours after stroke onset or symptom worsening. Passive exercise training begins on day 3 and is conducted once
RIC+Sham-Passive exercise group:RIC is administered twice daily for 7 days, starting within 24 hours after stroke onset or symptom worsening. Sham passive exercise training begins on day 3 and is per
Passive exercise group:Sham passive exercise training begins on Day 3 after stroke onset or symptom worsening and is performed once daily for 5 days.

Sponsors

Affiliated Hospital of Jiujiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Patients diagnosed with acute ischemic stroke within 0–24 hours of onset; 3.Study intervention can be initiated within 24 hours of symptom onset; 4.NIHSS score >= 4; 5.Informed consent form signed by either the patients themselves or their legally authorized representatives.

Exclusion criteria

Exclusion criteria: 1. Contraindications to ischemic conditioning therapy (1)Skin/soft tissue injury, fractures, or peripheral arterial disease in upper limbs; 2. Unstable vital signs (1)Systolic blood pressure 220 mmHg; (2)Heart rate 100 bpm; (3)Percutaneous oxygen saturation (SpO2) =92%; (4)Body temperature =38.5°C; 3. Upper limb fractures or other conditions preventing exercise training completion; 4. Underlying diseases and relevant treatment history (1)History of autoimmune diseases or malignancy; (2)Immunosuppressant use within the last 3 months; 5. Poor prognosis (1)Life expectancy =1 year; 6. Major organ dysfunction (1)Severe hepatic, pulmonary, cardiac, or renal dysfunction; 7. Bleeding and coagulation abnormalities (1)Coagulopathy or active bleeding; 8. Severe cardiovascular emergencies (1)Concurrent acute coronary syndrome or severe arrhythmia; 9. Lower extremity vascular disease (1)Venous thrombosis in both lower limbs; 10. Special physiological status in females (1)Known pregnancy, lactation, or positive pregnancy test; 11. Concurrent participation in other clinical trials (1)Concurrent enrollment in other drug or device clinical studies; 12. Other ineligible conditions (1)Other conditions deemed ineligible by the investigator.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale Score;

Secondary

MeasureTime frame
National Institute of Health stroke scale score;Barthel Index score;Water Swallowing Test ;Activity of Daily Living score;Glasgow coma scale score;

Countries

China

Contacts

Public ContactZhiying Chen

Affiliated Hospital of Jiujiang University

chenzhiying0627@126.com+86 137 6726 3459

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026